DaVita Inc. (NYSE:DVA) Given Average Rating of "Hold" by Brokerages

Shares of DaVita Inc. (NYSE:DVA - Get Free Report) have earned an average rating of "Hold" from the five brokerages that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $161.80.

A number of analysts have commented on the stock. Bank of America boosted their price target on shares of DaVita from $139.00 to $145.00 and gave the company an "underperform" rating in a research note on Wednesday, August 7th. Truist Financial lifted their price objective on shares of DaVita from $165.00 to $175.00 and gave the company a "hold" rating in a research note on Monday, October 7th. UBS Group increased their price target on shares of DaVita from $169.00 to $175.00 and gave the stock a "buy" rating in a report on Thursday, August 8th. Finally, Barclays lifted their price objective on DaVita from $150.00 to $164.00 and gave the company an "equal weight" rating in a research note on Thursday, October 31st.

DaVita Price Performance

Shares of DVA stock traded up $0.99 on Tuesday, hitting $167.98. 517,776 shares of the company's stock were exchanged, compared to its average volume of 824,427. DaVita has a 12 month low of $98.26 and a 12 month high of $169.12. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The company has a 50 day moving average of $158.34 and a 200 day moving average of $148.65. The stock has a market cap of $13.77 billion, a P/E ratio of 18.12, a price-to-earnings-growth ratio of 0.93 and a beta of 0.89.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). The company had revenue of $3.26 billion for the quarter, compared to the consensus estimate of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business's quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.85 EPS. On average, equities research analysts predict that DaVita will post 9.71 EPS for the current year.

Insider Buying and Selling

In other DaVita news, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction on Monday, September 16th. The stock was sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the completion of the sale, the chief executive officer now directly owns 837,835 shares of the company's stock, valued at $138,284,666.75. The trade was a 5.63 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On DaVita

Hedge funds have recently modified their holdings of the business. Tidal Investments LLC lifted its stake in shares of DaVita by 45.2% during the 3rd quarter. Tidal Investments LLC now owns 5,688 shares of the company's stock worth $932,000 after purchasing an additional 1,771 shares during the last quarter. Te Ahumairangi Investment Management Ltd boosted its holdings in shares of DaVita by 1.0% in the 3rd quarter. Te Ahumairangi Investment Management Ltd now owns 48,137 shares of the company's stock valued at $7,846,000 after buying an additional 500 shares in the last quarter. Toronto Dominion Bank grew its position in shares of DaVita by 6.9% in the 3rd quarter. Toronto Dominion Bank now owns 15,898 shares of the company's stock worth $2,606,000 after buying an additional 1,025 shares during the last quarter. Neo Ivy Capital Management bought a new position in shares of DaVita during the 3rd quarter worth approximately $726,000. Finally, M&T Bank Corp lifted its position in DaVita by 4.2% during the third quarter. M&T Bank Corp now owns 3,534 shares of the company's stock valued at $579,000 after acquiring an additional 143 shares during the last quarter. Hedge funds and other institutional investors own 90.12% of the company's stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.